{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Resveratrol", "brain tumor", "cancer therapy", "central nervous system", "glioblastoma", "medicinal herbs"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32990542", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1871520620666200929151139"], "Journal": {"ISSN": "1875-5992", "JournalIssue": {"Volume": "21", "Issue": "10", "PubDate": {"Year": "2021"}}, "Title": "Anti-cancer agents in medicinal chemistry", "ISOAbbreviation": "Anticancer Agents Med Chem"}, "ArticleTitle": "Protective Effect of Resveratrol against Glioblastoma: A Review.", "Pagination": {"StartPage": "1216", "EndPage": "1227", "MedlinePgn": "1216-1227"}, "Abstract": {"AbstractText": ["One of the most common tumors of the central nervous system is Glioblastoma (GBM).", "There is not still an appropriate cure for this malignant tumor. Plant-derived natural products have demonstrated great potential in cancer therapy, and Resveratrol (Res) is among them. Therefore, the current study focused on the protective effect of resveratrol against glioblastoma and its underlying mechanism.", "PubMed, Medline, Scopus, Web of Science, and Google Scholar were searched by using the following keywords: Resveratrol, Glioblastoma, Brain tumor, Cancer therapy, Medicinal herbs to July 2020.", "Res is a non-flavonoid polyphenol responsible for the protection of plants against pathogen attacks. Res has multiple pharmacological effects, including antioxidant, anti-inflammatory, anti-diabetic, and anti-tumor. Res is capable of penetration into the blood-brain barrier, making it suitable for brain tumor therapy. Besides, Res targets various molecular signaling pathways in cancer therapy.", "In the present review, it was found that Res administration is beneficial in GBM therapy by inhibition of proliferation, viability, and migration via modulation of molecular pathways."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, \u00dcniversite Caddesi No. 27, Orhanl\u0131, Tuzla, 34956 Istanbul, Turkey."}], "LastName": "Ashrafizadeh", "ForeName": "Milad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sabanci University Nanotechnology Research and Application Center (SUNUM), Tuzla, 34956, Istanbul, Turkey."}], "LastName": "Mohammadinejad", "ForeName": "Reza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran."}], "LastName": "Farkhondeh", "ForeName": "Tahereh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran."}], "LastName": "Samarghandian", "ForeName": "Saeed", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Anticancer Agents Med Chem", "NlmUniqueID": "101265649", "ISSNLinking": "1871-5206"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "Q369O8926L", "NameOfSubstance": "Resveratrol"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Central Nervous System Neoplasms"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Glioblastoma"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Protective Agents"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Resveratrol"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "3", "Day": "9"}, {"Year": "2020", "Month": "7", "Day": "15"}, {"Year": "2020", "Month": "7", "Day": "19"}, {"Year": "2020", "Month": "9", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "29", "Hour": "12", "Minute": "34"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32990542", "10.2174/1871520620666200929151139", "ACAMC-EPUB-110330"]}}]}